In the BioHarmony Drug Report Database

"Preview" Icon

Thiothixene

Navane (thiothixene) is a small molecule pharmaceutical. Thiothixene was first approved as Navane on 1982-01-01. It is used to treat psychotic disorders, schizophrenia, and schizophrenia spectrum and other psychotic disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 2A. In addition, it is known to target histamine H1 receptor.

 

Trade Name

 

Navane
 

Common Name

 

thiothixene
 

ChEMBL ID

 

CHEMBL1201
 

Indication

 

psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders
 

Drug Class

 

Typical antipsychotic

Image (chem structure or protein)

Thiothixene structure rendering